These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1652774)

  • 1. Kappa-opioid receptor-mediated thermonociceptive mechanisms in streptozotocin diabetes.
    Bansinath M; Ramabadran K; Turndorf H; Puig MM
    Physiol Behav; 1991 Apr; 49(4):729-33. PubMed ID: 1652774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the benzomorphan kappa-opiate, MR 2266 and its (+) enantiomer MR 2267, on thermonociceptive reactions in different strains of mice.
    Bansinath M; Ramabadran K; Turndorf H; Puig MM
    Neurosci Lett; 1990 Sep; 117(1-2):212-7. PubMed ID: 1963214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hyperalgesic effect of naloxone is attenuated in streptozotocin-diabetic mice.
    Ramabadran K; Bansinath M; Turndorf H; Puig MM
    Psychopharmacology (Berl); 1989; 97(2):169-74. PubMed ID: 2498924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of yohimbine on nociceptive threshold in normoglycemic and streptozotocin-treated hyperglycemic mice.
    Bansinath M; Ramabadran K; Turndorf H; Puig MM
    Pharmacol Biochem Behav; 1989 Jun; 33(2):459-63. PubMed ID: 2813484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycemic control of pain threshold in diabetic and control rats.
    Lee JH; McCarty R
    Physiol Behav; 1990 Feb; 47(2):225-30. PubMed ID: 2159159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of opioid receptors in diabetes and hyperglycemia-induced changes in pain threshold in the rat.
    Akunne HC; Soliman KF
    Psychopharmacology (Berl); 1987; 93(2):167-72. PubMed ID: 2827214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists.
    Kamei J; Ohhashi Y; Aoki T; Kawasima N; Kasuya Y
    Brain Res; 1992 Feb; 571(2):199-203. PubMed ID: 1319265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strain differences in the hyperalgesic effect of a novel kappa receptor agonist, U-50488H in mice.
    Ramabadran K
    Eur J Pharmacol; 1984 Mar; 98(3-4):425-7. PubMed ID: 6327334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of naloxone and Mr 2266 on thermonociceptive reactions in diabetic mice.
    Ramabadran K; Bansinath M; Turndorf H; Puig MM
    NIDA Res Monogr; 1989; 95():528-9. PubMed ID: 2561849
    [No Abstract]   [Full Text] [Related]  

  • 10. Differential modulation of nociceptive responses to mu and kappa opioid receptor directed drugs by blood glucose in experimentally induced diabetes rats.
    Tandon M; Srivastava RK; Nagpal RK; Khosla P; Singh J
    Indian J Exp Biol; 2000 Mar; 38(3):242-8. PubMed ID: 10927866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperglycaemia as a factor affecting kappa-opiate agonist-induced inhibition of the gastrointestinal transit in mice.
    Ramabadran K; Bansinath M; Turndorf H; Puig MM
    J Pharm Pharmacol; 1989 Jul; 41(7):496-8. PubMed ID: 2570861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spinal mu-, delta- and kappa-opioid receptors mediate intense stimulation-elicited inhibition of a nociceptive reflex in the rat.
    Romita VV; Henry JL
    Eur J Pharmacol; 1998 Sep; 357(2-3):127-38. PubMed ID: 9797028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central kappa- and mu-opiate receptors mediate ACTH-release in rats.
    Pfeiffer A; Herz A; Loriaux DL; Pfeiffer DG
    Endocrinology; 1985 Jun; 116(6):2688-90. PubMed ID: 2986960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible involvement of cholinergic and opioid receptor mechanisms in fluoxetine mediated antinociception response in streptozotocin-induced diabetic mice.
    Anjaneyulu M; Chopra K
    Eur J Pharmacol; 2006 May; 538(1-3):80-4. PubMed ID: 16650402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exposure to mosquitoes, Aedes togoi (Theo.), induces and augments opioid-mediated analgesia in mice.
    Colwell DD; Kavaliers M
    Physiol Behav; 1990 Sep; 48(3):397-401. PubMed ID: 2176291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examination of spinal monoamine receptors through which brainstem opiate-sensitive systems act in the rat.
    Jensen TS; Yaksh TL
    Brain Res; 1986 Jan; 363(1):114-27. PubMed ID: 3004638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opiate suppression of LH secretion involves central receptors different from those mediating opiate effects on prolactin secretion.
    Pfeiffer DG; Pfeiffer A; Almeida OF; Herz A
    J Endocrinol; 1987 Sep; 114(3):469-76. PubMed ID: 2822829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analgesic effects of mu-, delta- and kappa-opiate agonists and, in particular, dynorphin at the spinal level.
    Przewłocki R; Stala L; Greczek M; Shearman GT; Przewłocka B; Herz A
    Life Sci; 1983; 33 Suppl 1():649-52. PubMed ID: 6141505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spinal antinociceptive actions and naloxone reversibility of intravenous mu- and kappa-opioids in spinalized rats: potency mismatch with values reported for spinal administration.
    Parsons CG; West DC; Headley PM
    Br J Pharmacol; 1989 Oct; 98(2):533-43. PubMed ID: 2555012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid systems in the response to inflammatory pain: sustained blockade suggests role of kappa- but not mu-opioid receptors in the modulation of nociception, behaviour and pathology.
    Millan MJ; Colpaert FC
    Neuroscience; 1991; 42(2):541-53. PubMed ID: 1654538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.